Eliem Therapeutics earnings beat by 0.04, revenue was in line with estimates
About 67% of ELYM Old's investor base is looking to short. The analysis of current outlook of investing in ELYM Old suggests that many traders are alarmed regarding ELYM Old's prospects. ELYM Old's investing sentiment overview a quick insight into current market opportunities from investing in ELYM Old. Many technical investors use ELYM Old stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
ELYM |
Eliem Therapeutics earnings beat by 0.04, revenue was in line with estimates
Read at investing.com
![]() |
ELYM Old Fundamental Analysis
We analyze ELYM Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ELYM Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ELYM Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
ELYM Old is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
ELYM Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ELYM Old stock to make a market-neutral strategy. Peer analysis of ELYM Old could also be used in its relative valuation, which is a method of valuing ELYM Old by comparing valuation metrics with similar companies.
Peers
ELYM Old Related Equities
PEPG | PepGen | 29.63 | ||||
STTK | Shattuck Labs | 10.92 | ||||
RZLT | Rezolute | 4.48 | ||||
MOLN | Molecular Partners | 3.71 | ||||
ANTX | AN2 Therapeutics | 2.70 | ||||
HCWB | HCW Biologics | 2.70 | ||||
PHVS | Pharvaris | 2.19 | ||||
IPSC | Century Therapeutics | 1.49 | ||||
CSBR | Champions Oncology | 0.59 | ||||
AVTE | Aerovate Therapeutics | 0.41 | ||||
ACRV | Acrivon Therapeutics, | 0.56 | ||||
ADAG | Adagene | 0.99 | ||||
MNOV | MediciNova | 2.38 | ||||
PMVP | Pmv Pharmaceuticals | 2.84 | ||||
ANEB | Anebulo Pharmaceuticals | 3.33 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in ELYM Stock
If you are still planning to invest in ELYM Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ELYM Old's history and understand the potential risks before investing.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
CEOs Directory Screen CEOs from public companies around the world | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |